Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Roche - Transforming the journey for HER2+ breast cancer patients

Transforming the experience of patients with HER2+ BC with recent clinical trials of PH FDC SC

Date

02 Dec 2022

Session

Roche - Transforming the journey for HER2+ breast cancer patients

Topics

Tumour Site

Breast Cancer

Presenters

Shu Wang

Authors

S. Wang

Author affiliations

  • Breast Disease Center, Peking University People's Hospital, 100044 - Beijing/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.